VSIR and acute myeloid leukemia: We found that 13F3 significantly reduced C1498FF–mPD-1H AML growth in PD-1H–KO mice (Supplemental Figure 13, A–C), with an effect similar to that seen in B6 WT mice (Figure 4E).